December 23, 2020
4 min watch
Save
Geneoscopy RNA-FIT has high sensitivity for colorectal cancer
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this exclusive video, George Catinis, MD, medical director at the New Orleans Research Institute, discusses an RNA-FIT colorectal cancer screening test developed by Geneoscopy.
In a study presented at the Association for Molecular Pathology 2020 Annual Meeting, researchers found that the test had a sensitivity of 95% for detecting colorectal cancer.
Published by:
Sources/Disclosures
Collapse
Source:
Disclosures:
Catinis reports that he is an investor in Geneoscopy.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.